Advertisement

Pituitary

, Volume 16, Issue 3, pp 333–340 | Cite as

Evaluation of depression, quality of life and body image in patients with Cushing’s disease

  • Nilufer Alcalar
  • Sedat Ozkan
  • Pinar Kadioglu
  • Ozlem Celik
  • Penbe Cagatay
  • Baris Kucukyuruk
  • Nurperi Gazioglu
Article

Abstract

The aim of this study was to evaluate patients with Cushing’s disease (CD) who had undergone transsphenoidal surgery in terms of depression, quality of life (QoL), and perception of body image in comparison to healthy controls. Forty patients with CD and 40 healthy controls matched for demographic characteristics were included in the study. The subjects were evaluated with the Beck depression inventory (BDI), the health survey-short form (SF-36) and the multidimensional body-self relations questionnaire (MBSRQ). Subgroups of the patients with CD were formed on the basis of remission status and BDI scores. In this study, QoL in the general health category and body image were lower in the patients with CD than in the healthy subjects. However, no differences in depression scores were found between the two groups. When the CD group was evaluated according to remission rate, the mean BDI score was significantly higher in the CD patients without remission than in both the CD patients with remission and the healthy subjects (p = 0.04). However, the physical functioning, bodily pain and general health scores of the CD patients without remission on the SF-36 questionnaire were lower than in the CD patients in remission and the healthy subjects (p = 0.002, p = 0.04, p = 0.002, respectively). Fitness evaluation, health evaluation and body areas satisfaction scores of the MBSRQ were significantly different in the three groups (p = 0.003, p = 0.009 and p = 0.001, respectively). In this study, patients with CD were found to have lower QoL, lower body image perception and higher levels of depression compared to healthy controls, particularly if the disease is persistant despite surgery.

Keywords

Cushing’s disease Pituitary surgery Depression Quality of life Body image 

Notes

Acknowledgments

This research did not receive any specific grant from any funding agency in the public, commercial, or not-for-profit sector.

Conflict of interest

The authors declare no conflicts of interest that could be perceived as prejudicing the impartiality of the research reported.

References

  1. 1.
    Bertagna X, Guignat L, Groussin L, Bertherat J (2009) Cushing’s disease. Best Pract Res Clin Endocrinol Metab 23:607–623CrossRefPubMedGoogle Scholar
  2. 2.
    Pivonello R, De Leo MC, De Leo M, Lombardi G, Colao A (2008) Cushing’s Syndrome. Endocrinol Metab Clin N Am 37:135–149CrossRefGoogle Scholar
  3. 3.
    Hofmann BM, Hlavac M, Martinez R, Buchfelder M, Müler OA, Fahlbusch R (2008) Long-term results after microsurgery for Cushing disease: experience with 426 primary operations over 35 years. J Neurosurg 108:9–18CrossRefPubMedGoogle Scholar
  4. 4.
    Patil CG, Prevedello DM, Lad SP, Vance ML, Thorner MO, Katznelson L, Laws ER (2008) Late recurrences of Cushing’s disease after ınitial successful transsphenoidal surgery. J Clin Endocrinol Metab 93:358–362CrossRefPubMedGoogle Scholar
  5. 5.
    Mancini T, Porcelli T, Giustina A (2010) Treatment of Cushing’s disease: overview and recent findings. Ther Clin Risk Manag 6:505–516PubMedGoogle Scholar
  6. 6.
    Sonino N, Fava GA, Raffi AR, Boscaro M, Fallo F (1998) Clinical correlates of major depression in Cushing’s disease. Psychopathology 31:302–306CrossRefPubMedGoogle Scholar
  7. 7.
    Sonino N, Fava GA (1998) Psychosomatic aspects of Cushing’s disease. Psychother Psychosom 67:140–146CrossRefPubMedGoogle Scholar
  8. 8.
    Van Aken MO, Pereira AM, Biermasz NR, Van Thiel SW, Hoftijzer HC, Smit JW, Roelfsema F, Lamberts SWJ, Romijn JA (2005) Quality of life in patients after long-term biochemical cure of Cushing’s disease. J Clin Endocrinol Metab 90:3279–3286CrossRefPubMedGoogle Scholar
  9. 9.
    Sonino N, Fallo F, Fava GA (2010) Psychosomatic aspects of Cushing’s disease. Rev Endocr Metab Disord 11:95–104CrossRefPubMedGoogle Scholar
  10. 10.
    Lindsay JR, Nansel T, Baid S, Gumowski J, Nieman KL (2006) Long-term ımpaired quality of life in Cushing’s syndrome despite ınitial ımprovement after surgical remission. J Clin Endocrinol Metab 91:447–453CrossRefPubMedGoogle Scholar
  11. 11.
    Thompson SK, Hayman AV, Ludlam WH, Deveney CW, Loriaux DL, Sheppard BC (2007) Improved quality of life after bilateral laparoscopic adrenalectomy for Cushing’s disease: a 10-Year experience. Ann Surg 245:790–794CrossRefPubMedGoogle Scholar
  12. 12.
    Sonino N, Fava GA (1998) Psychological aspects of endocrine disease. Clin Endocrinol (Oxf) 49:1–7CrossRefGoogle Scholar
  13. 13.
    Heald AH, Ghosh S, Bray S, Gibson C, Anderson SG, Buckler H, Fowler HL (2004) Long-term negative impact on quality of life in patients with successfully treated Cushing’s disease. Clin Endocrinol (Oxf) 61:458–465CrossRefGoogle Scholar
  14. 14.
    Kelly WF (1996) Psychiatric aspects of Cushing’s syndrome. Q J Med 89:543–551CrossRefGoogle Scholar
  15. 15.
    Webb SM, Badia X, Barahona MJ, Colao A, Strasburger CJ, Tabarin A, Van Aken MO, Pivonello R, Stalla G, Lamberts SWJ, Glusman JE (2008) Evaluation of health-related quality of life in patients with Cushing’s syndrome with a new questionnaire. Eur J Endocrinol 58:623–630CrossRefGoogle Scholar
  16. 16.
    Bech P, Gudex C, Staehr Johansen K (1996) The WHO (ten) well-being index: validation in diabetes. Psychother Psychosom 65:183–190CrossRefPubMedGoogle Scholar
  17. 17.
    Ryff CS, Singer B (1996) Psychological well-being. Psychother Psychosom 65:14–23CrossRefPubMedGoogle Scholar
  18. 18.
    Nieman LK, Biler BMK, Findling JW, Newell Price J, Savage MO, Stewart PM, Montori VM (2008) The diagnosis of Cushing syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93:1526–1540CrossRefPubMedGoogle Scholar
  19. 19.
    Beck AT, Ward Ch, Mendelson M, Mosk J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571CrossRefPubMedGoogle Scholar
  20. 20.
    Cohen SI (1980) Cushing’s syndrome: a psychiatric study of 29 patients. Br J Psychiatry 136:120–124CrossRefPubMedGoogle Scholar
  21. 21.
    Loosen PT, Chamliss B, Debold CR, Shelton R, Orth DN (1992) Psychiatric phenomenology in Cushing’s disease. Pharmacopsychiatry 25:192–198CrossRefPubMedGoogle Scholar
  22. 22.
    Sonino N, Zielezny M, Fava GA, Fallo F, Boscaro M (1998) Risk factors and long term outcome in pituitary-dependent Cushing’s disease. Psychother Psychosom 67:140–146CrossRefPubMedGoogle Scholar
  23. 23.
    Sonino N, Fava GA (2001) Psychiatric disorders associated with Cushing’s syndrome. CNS Drugs 15:361–373CrossRefPubMedGoogle Scholar
  24. 24.
    Kelly WF, Checkley SA, Bender DA (1980) Cushing’s syndrome, tryptophan and depression. Br J Psychiatry 136:125–132CrossRefPubMedGoogle Scholar
  25. 25.
    Tiemensma J, Biermasz NR, van der Mast RC, Wassenaar MJ, Middelkoop HA, Pereira AM, Romijn JA (2010) Increased prevalence of psychopathology and maladaptive personality traits after long-term cure of Cushing’s disease. J Clin Endocrinol Metab 95(12):E129–E141CrossRefPubMedGoogle Scholar
  26. 26.
    Jeffcoate WJ, Silverstone JT, Edwars CR, Beser GM (1979) Psychiatric manifestations of Cushing’s syndrome: response to lowering of plasma cortisol. Q J Med 48:465–472PubMedGoogle Scholar
  27. 27.
    Castinetti F, Fassnacht M, Johanssen S, Terzolo M, Bouchard P, Chanson P, Do Cao C, Morange I, Pico A, Ouzounian S, Young J, Hahner S, Brue T, Allolio B, Conte-Devolx B (2009) Merits and pitfalls of mifepristone in Cushing’s syndrome. Eur J Endocrinol 160:1003–1010CrossRefPubMedGoogle Scholar
  28. 28.
    Starkman MN, Schteingart DE, Schork MA (1986) Cushing’s syndrome after treatment: changes in cortisol and ACTH levels and amelioration of the depressive syndrome. Psychiatry Res 19:177–188CrossRefPubMedGoogle Scholar
  29. 29.
    Dorn LD, Burgess ES, Friedman T, Dubbert B, Gold PW, Chrousos GP (1997) The longitudinal course of psychopathology in Cushing’s syndrome after correction of hypercortisolism. J Clin Endocrinol Metab 82:912–919CrossRefPubMedGoogle Scholar
  30. 30.
    Sonino N, Bonnini S, Fallo F, Boscaro M, Fava GA (2006) Personality characteristics and quality of life in patients treated for Cushing’s syndrome. Clin Endocrinol 64:314–318CrossRefGoogle Scholar
  31. 31.
    Van der Klaauw AA, Kars M, Biermasz NR, Roelfsema F, Dekkers OM, Corssmit EP, Van Aken MO, Havekes B, Pereira AM, Pijl H, Smit JW, Romijn JA (2008) Disease specific impairments in quality of life during long term follow-up of patients with different pituitary adenomas. Clin Endocrinol (Oxf) 69:775–784CrossRefGoogle Scholar
  32. 32.
    Johnson MD, Woodburn CJ, Vance ML (2003) Quality of life in patients with pituitary adenoma. Pituitary 6:81–87CrossRefPubMedGoogle Scholar
  33. 33.
    Lindholm J, Juul S, Jorgenson JO, Astrup J, Bjerre P, Feldt-Rasmussen U, Hagen C, Jorgensen J, Kosteljanetz M, Kristensen L, Laurberg P, Schmidt K, Weeke J (2001) Incidence and late prognosis of Cushing’s syndrome: a population –based study. J Clin Endocrinol Metab 86:117–123CrossRefPubMedGoogle Scholar
  34. 34.
    Hawn MT, Cook D, Deveney C, Sheppard BC (2002) Quality of life after bilateral adrenalectomy for Cushing’s disease. Surgery 132:1064–1068CrossRefPubMedGoogle Scholar
  35. 35.
    Tiemensma J, Daskalakis NP, van der Veen EM, Ramondt S, Richardson SK, Broadbent E, Romijn JA, Pereira AM, Biermasz NR, Kaptein AA (2012) Drawings reflect a new dimension of the psychological ımpact of long-term remission of Cushing’s syndrome. J Clin Endocrinol Metab. (Epub ahead of print)Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Nilufer Alcalar
    • 1
  • Sedat Ozkan
    • 1
  • Pinar Kadioglu
    • 2
  • Ozlem Celik
    • 2
  • Penbe Cagatay
    • 3
  • Baris Kucukyuruk
    • 4
  • Nurperi Gazioglu
    • 4
  1. 1.Department of Consultation Liaison Psychiatry, Istanbul Medical SchoolIstanbul UniversityÇapa, IstanbulTurkey
  2. 2.Division of Endocrinology and Metabolism, Department of Internal Medicine, Cerrahpasa Medical SchoolIstanbul UniversityIstanbulTurkey
  3. 3.Department of Biostatistics, Istanbul Medical SchoolIstanbul UniversityIstanbulTurkey
  4. 4.Department of Neurosurgery, Cerrahpasa Medical SchoolIstanbul UniversityIstanbulTurkey

Personalised recommendations